Treating Non-Hodgkin Lymphoma

If you’ve been diagnosed with non-Hodgkin lymphoma (NHL), your cancer care team will discuss your options with you. It’s important to weigh the benefits of each treatment option against the possible risks and side effects.

This information is about treating non-Hodgkin lymphoma in adults. Treatment in children is slightly different. Learn more in Treating Lymphoma in Children.

Who treats non-Hodgkin lymphoma?

You may have different types of doctors on your treatment team. These doctors could include a:

  • Medical oncologist or hematologist who treats lymphoma with chemotherapy, immunotherapy, and targeted therapy.
  • Radiation oncologist who treats cancer with radiation therapy.
  • Bone marrow transplant doctor who specializes in treating cancer and other diseases with bone marrow or stem cell transplants.

You might have many other specialists on your treatment team as well, including physician assistants (PAs), nurse practitioners (NPs), nurses, nutrition specialists, pharmacists, social workers, and other health professionals.

How is non-Hodgkin lymphoma treated?

Chemotherapy, immunotherapy, and radiation therapy are the main treatments for non-Hodgkin lymphoma. You might get one or more treatments, depending on your situation.

Some people are treated with a stem cell transplant, especially if other treatments don't work. Surgery is rarely used to treat NHL. It is mainly used to remove tissue for a biopsy to diagnose the lymphoma, or to treat a blocked bowel or other problems the lymphoma causes.

Common treatment approaches

Treatment for NHL depends on the type of lymphoma and its stage (extent). Your treatment team will also consider your overall health, personal preferences, and other factors.

Other medicines used to treat lymphoma

Other medicines can also be useful in treating some types of lymphoma.

MALT lymphoma

Mucosa-associated lymphoid tissue (MALT) lymphoma usually starts in the stomach. It is linked to infection with the bacterium H. pylori. Treatment of the infection can often make the lymphoma go away, especially in early-stage disease.

This is most often done with a combination of antibiotics along with medicines called proton pump inhibitors, which lower stomach acid levels. Not all gastric (stomach) MALT lymphomas go away after getting rid of H. pylori. Some people need more treatment. 

Splenic marginal zone B-cell lymphoma

In a similar way, splenic marginal zone B-cell lymphoma is sometimes linked to infection with the hepatitis C virus. Treating the infection with anti-viral medicines can sometimes shrink these lymphomas or even make them go away.

Making treatment decisions

It’s important to discuss all your treatment options with your cancer care team so you can make the decision that best fits your needs. This includes talking about the goals and possible side effects of each treatment. You may feel like you need to decide quickly, but it’s important to give yourself time to absorb the information you learn.

Ask questions if you are unsure about anything.

Questions to ask before non-Hodgkin lymphoma treatment

Understanding your diagnosis and choosing a treatment plan

  • What are my treatment options?
  • Which do you recommend and why?
  • How much experience do you have treating NHL?
  • Does one type of treatment lessen the chance of the lymphoma coming back more than another?
  • How quickly do we need to decide on treatment?
  • Should I get a second opinion? How do I do that?

What to expect during treatment

  • What should I do to be ready for treatment?
  • How long will treatment last?
  • What will it be like? Where will it be done?
  • How will treatment affect my daily activities? Can I still work full time?
  • Can I exercise during treatment? If so, what kind should I do and how often?
  • Are there any limits on what I can do?
  • How will we know if the treatment is working?
  • What are the chances the lymphoma will come back (recur)?
  • What will we do if this happens?

Side effects and long-term effects

  • What are the risks or side effects of this treatment?
  • Can I do anything to manage or reduce these side effects?
  • Will I still be able to have children after my treatment?
  • Should I see a fertility specialist?
  • What symptoms or side effects should I tell you about right away?
  • How can I reach you on nights, holidays, or weekends?

Support and resources

  • What if I don’t have transportation to and from treatment?
  • Is there someone I can talk to if I feel overwhelmed, depressed, or distressed?
  • What if I need social support during treatment because my family lives far away?
  • Who do I talk to if I’m concerned about the costs and insurance coverage for my treatment?

Other things to consider

Seeking a second opinion: If time allows, consider getting a second opinion. This can give you more information and help you feel more confident about the treatment plan you choose.

Clinical trials: Clinical trials study new treatments and may offer access to promising options not widely available. They are also how doctors learn better ways to treat cancer. Ask your doctor about clinical trials you may qualify for.

Integrative (holistic) and alternative methods: You may hear about herbs, diets, acupuncture, massage, or other ways to relieve your symptoms or treat your cancer. Integrative therapies are used with standard care, while alternative therapies replace it. Some of these may help with symptoms, but many aren’t proven to work. Some could even be harmful. Talk with your care team first to make sure they’re safe and won’t interfere with treatment.

Palliative and supportive care

For most people with NHL, treating the lymphoma itself is the main concern. But relieving your pain and other symptoms is also important. Treating your lymphoma may help with these problems over time, but you might also need other treatments to relieve your symptoms.

This type of treatment is sometimes called palliative care or supportive care. You may get this care at any stage of your cancer, and it can be given along with cancer treatment.

Antibiotics and anti-virals

Some chemotherapy drugs (fludarabine and other purine analogs) as well as the antibody drug alemtuzumab (Campath, Lemtrada) can put you at high risk of certain types of infections, including:

  • CMV (a virus)
  • Pneumocystis pneumonia (PCP), which is caused by the fungus Pneumocystis jirovecii

These infections are mainly seen in people with impaired immune systems.

An anti-viral medicine like acyclovir is often given to try to prevent CMV infections. To help prevent PCP, a sulfa antibiotic such as trimethoprim with sulfamethoxazole (Septra or Bactrim) is often given. Other treatments are available for people who are allergic to sulfa medicines.

If you do get an infection, you might need antibiotics and anti-viral medicines to treat it. You might need higher doses or different medicines than the ones used to prevent infection.

Intravenous immunoglobulin (IVIG)

Some people with NHL have low levels of antibodies (immunoglobulins). Antibodies are immune system proteins that fight infections. If you have a low level of antibodies, this can lead to lung and sinus infections that keep coming back.

Low antibody levels can be caused by the lymphoma itself or by some treatments, including rituximab and similar drugs, CAR T-cell therapy, and bispecific antibodies.

The level of antibodies in your blood can be checked with a blood test. If the level is low, antibodies from donors can be put into a vein (IV) to help prevent infections. This is called intravenous immunoglobulin (IVIG). IVIG is often given once a month at first, but it may be given less often based on blood tests of antibody levels.

For more information on infections, see Infections in People with Cancer.

Chemotherapy (chemo) and some other lymphoma treatments can affect your bone marrow, where new blood cells are made. This can lead to low levels of some types of blood cells.

Low white blood cell count

Your body needs white blood cells to fight infection, especially certain white blood cells called neutrophils. Having too few neutrophils (neutropenia) can lead to serious or even life-threatening infections.

If your chemo is likely to cause neutropenia, you might get shots of a white blood cell growth factor to help keep your neutrophil count up. You might also get these shots if your count is already low. This can lower your risk of serious infection and help keep your chemo on schedule.

Examples of white blood cell growth factors include:

  • Filgrastim (Neupogen) and similar drugs, which are given as a shot every day for several days.
  • Pegfilgrastim (Neulasta) and similar drugs, which are given once each chemo cycle. They can be given as a shot or with a small device worn on the skin that gives the dose automatically.

These are not given on the same day as chemo, because giving them too close to chemo can make neutropenia worse. They are usually started at least one day after chemo ends.

If you have neutropenia and get a fever or other signs of infection, call your care team right away. You'll need treatment with antibiotics.

Low platelet count

Platelets help blood to clot, which stops bleeding. If your platelet count gets very low, it can lead to serious bleeding. Platelet transfusions can often help prevent this.

If you have NHL, your platelet count can also become low. This can happen when your platelets are destroyed by abnormal antibodies. It is called immune thrombocytopenia (ITP). Before diagnosing this, your healthcare team will often need to check your bone marrow to make sure there isn’t another cause for the low platelet counts.

Platelet transfusions don’t usually help to treat ITP, because the antibodies just destroy the new platelets, too. Instead, ITP can be treated in a few other ways:

  • With medicines that affect the immune system, like corticosteroids and intravenous immunoglobulin (IVIG).
  • By removing your spleen, because after the antibodies stick to the platelets, they are destroyed in the spleen.
  • With thrombopoietin receptor agonists (TPO-RAs) such as eltrombopag (Promacta) or romiplostim (Nplate). These can help your body make more platelets.

Low red blood cell count

Some people develop low red blood cell counts (anemia) from NHL or its treatment. This can lead to feeling tired, lightheaded, or short of breath.

Anemia that is causing symptoms can be treated with red blood cell transfusions.

Medicines such as epoetin alfa (Epogen, Procrit) or darbepoetin alfa (Aranesp) may also be used. These medicines help your body make more red blood cells. However, they can raise the risk of blood clots and may lead to worse cancer outcomes. They are generally only used for people who decline blood transfusions, and with close monitoring.

In some people with NHL, abnormal antibodies can also lower red blood cell counts. This is called autoimmune hemolytic anemia (AIHA).

It can be treated with medicines that affect the immune system, such as corticosteroids and intravenous immunoglobulin (IVIG). Removing the spleen is also an option. If you are being treated with the chemo drug fludarabine (Fludara) when the AIHA develops, the drug itself may be the cause. In this case, your cancer care team may stop your fludarabine.

Sometimes, the treatments you get to control your symptoms are similar to the treatments used to treat cancer. For example:

  • When lymph nodes become enlarged, they may press on nerves and cause pain. Radiation therapy to these areas may help relieve the pain.
  • You might also be given pain medicines, ranging from ibuprofen and similar drugs to more potent medicines such as opioids (like morphine).
  • Nausea and loss of appetite can be treated with medicines and high-calorie food supplements.
  • If the lymphoma has spread to your lungs, you might get short of breath. Oxygen may be used to help treat this.

Always tell your cancer care team about any symptoms you have, including any side effects from treatment. There are often ways to help control or lessen these symptoms. This is an important part of your care and overall treatment plan.

Help getting through cancer treatment

Your cancer care team will be your first source of information and support, but there are other resources for help when you need it. Hospital or clinic-based support services can also be an important part of cancer care. This might include nursing or social work services, financial aid, nutritional advice, rehab, or spiritual help.

The American Cancer Society also has programs and services to help you get through treatment, including rides to treatment, lodging, and more. Contact the ACS cancer helpline for more information.

Choosing to stop treatment or choosing no treatment at all

When treatments have been tried and are no longer controlling your cancer, it could be time to weigh the benefits and risks of continuing to try new treatments. Whether or not you continue treatment, there are still things you can do to help maintain or improve your quality of life.

Choosing not to treat your cancer

Some people might not want to be treated at all, especially if the cancer is advanced. There are many reasons you might decide not to get treatment, but it’s important to talk to your cancer care team as you make that decision. Remember that even if you choose not to treat your cancer, you can still get supportive care to help with pain or other symptoms.

Hospice care

People with advanced cancer who are expected to live less than 6 months may want to consider hospice care. Hospice care is designed to provide the best possible quality of life for people near the end of life.

You and your family are encouraged to talk with your cancer care team about hospice care options, which include hospice care at home, a special hospice center, or other healthcare locations.

Nursing care and special equipment can make staying at home a workable option for many families.

The treatment information given here is not official policy of the American Cancer Society and is not intended as medical advice to replace the expertise and judgment of your cancer care team. It is intended to help you and your family make informed decisions, together with your doctor. Your doctor may have reasons for suggesting a treatment plan different from these general treatment options. Don't hesitate to ask your cancer care team any questions you may have about your treatment options.

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

Bohlius J, Bohlke K, Castelli R, et al. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. J Clin Oncol. 2019;37(15):1336-1351.

Ferrell BR, Temel JS, Temin S, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(1):96-112.

Hayden PJ, Roddie C, Bader P, et al. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Ann Oncol. 2022;33(3):259-275.

Hermine O, Lefrère F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347(2):89-94.

Jäger U, Barcellini W, Broome CM, et al. Diagnosis and management of autoimmune hemolytic anemia in patients with warm and cold antibodies: recommendations from the First International Consensus Meeting. Blood Rev. 2020;41:100648.

Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829-3866.

Schiffer CA, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2018;36(3):283-299.

Smith TJ, Bohlke K, Lyman GH, et al. Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2015;33(28):3199-3212.

Taplitz RA, Kennedy EB, Bow EJ, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol. 2018;36(30):3043-3054.

Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342(8871):575-577.

Last Revised: October 12, 2026

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.